Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses
- PMID: 3498566
- PMCID: PMC1542677
Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses
Abstract
Serum IgD levels in individuals infected with the human immunodeficiency viruses (HIV) were studied as a means of monitoring the character and timing of B cell activation in individuals with this infection. Significantly increased levels of IgD were characteristic of homosexual men who were HIV seropositive but asymptomatic or mildly symptomatic. The hyper IgD globulinaemia became progressively more pronounced in patients with increasingly severe infection and reached its most marked level in patients with AIDS-related complex (ARC). In ARC patients, IgD levels were increased 8.8-fold above normal which was disproportionately greater than the 2.4-fold increase in IgG, the 1.8-fold increase in IgA and the 1.6-fold increase in IgM. IgD levels declined in AIDS patients (although remained elevated compared to controls). The data suggest that an unusual type of B cell activation is responsible for the unique pattern of hypergammaglobulinaemia seen in this disease and that the B cell activation occurs early in the pathogenesis of HIV infection, often before development of symptoms, and continues throughout the course of infection.
Similar articles
-
B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters.Clin Exp Immunol. 1988 Mar;71(3):410-6. Clin Exp Immunol. 1988. PMID: 3260155 Free PMC article.
-
IgD production and other lymphocyte functions in HIV infection: immaturity and activation of B cells at different clinical stages.Clin Exp Immunol. 1989 Jan;75(1):7-11. Clin Exp Immunol. 1989. PMID: 2784730 Free PMC article.
-
Serum IgD behaviour in HIV-1 infected patients.Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):6-10. Allergol Immunopathol (Madr). 1991. PMID: 1950942
-
Immunoregulatory defects associated with infection with the AIDS virus, HTLV-III.Concepts Immunopathol. 1987;4:243-60. Concepts Immunopathol. 1987. PMID: 3297337 Review. No abstract available.
-
Immunoglobulins and hypersensitivity in human immunodeficiency virus (HIV) infection.J Allergy Clin Immunol. 1989 Jul;84(1):1-4. doi: 10.1016/0091-6749(89)90170-x. J Allergy Clin Immunol. 1989. PMID: 2666481 Review. No abstract available.
Cited by
-
Generation of human monoclonal antibodies to human immunodeficiency virus.Proc Natl Acad Sci U S A. 1989 Mar;86(5):1624-8. doi: 10.1073/pnas.86.5.1624. Proc Natl Acad Sci U S A. 1989. PMID: 2922401 Free PMC article.
-
Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells.J Virol. 2007 Jun;81(11):5872-81. doi: 10.1128/JVI.02542-06. Epub 2007 Mar 28. J Virol. 2007. PMID: 17392362 Free PMC article.
-
Alterations in peripheral blood B-cell populations in SHIV89.6P-infected macaques (Macacca fascicularis).Comp Med. 2011 Jun;61(3):269-77. Comp Med. 2011. PMID: 21819698 Free PMC article.
-
B cell responses to HIV and the development of human monoclonal antibodies.Clin Exp Immunol. 1992 May;88(2):189-202. doi: 10.1111/j.1365-2249.1992.tb03061.x. Clin Exp Immunol. 1992. PMID: 1572084 Free PMC article. Review.
-
New insights into the enigma of immunoglobulin D.Immunol Rev. 2010 Sep;237(1):160-79. doi: 10.1111/j.1600-065X.2010.00929.x. Immunol Rev. 2010. PMID: 20727035 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous